As the ADC landscape becomes more competitive, the limited availability of targets and antigens highlights the need to diversify payload modes of action to address cancers with high unmet needs.

As part of the World ADC Series, the 2nd ADC Payload Summit returns to Boston to help you turbocharge your ADCs by platforming cutting-edge work into diverse and novel payload categories.

With new data on underutilized MOAs such as degraders, RNA polymerase II inhibitors, immunomodulators, gene silences, and splice modulators, don't miss this opportunity to meet with fellow peers to explore the merits and challenges of diverse payloads to help you drive the potency of your next first-in-class ADC.

Event link here.